ResMed Inc. stock rises Thursday, outperforms market
Shares of ResMed Inc. RMD inched 0.56% higher to $233.88 Thursday, on what proved to be an all-around mixed trading session ...
ResMed Inc. stock rises Tuesday, still underperforms market
Shares of ResMed Inc. RMD inched 0.61% higher to $232.58 Tuesday, on what proved to be an all-around positive trading session ...
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
These Stocks Moved the Most Today: Honda, Qualcomm, Broadcom, Lilly, ResMed, Tesla, Walmart, Rumble, and More
Honda and Nissan begin merger talks with a plan for the combination to be completed in 2026, Qualcomm scores a victory in its ...
ETF Daily News2d
ResMed (NYSE:RMD) Shares Gap Down – Time to Sell?
Shares of ResMed Inc. (NYSE:RMD – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $237.27, but opened at $230.21. ResMed shares last traded at $226 ...
Top Stock Movers Now: Broadcom, AMD, ResMed, and More
Chip stocks advanced, led by Broadcom ( AVGO) after UBS analysts raised their price target for the stock, citing the ...
William Blair Comments on ResMed’s Q2 Earnings (NYSE:RMD)
Investment analysts at William Blair issued their Q2 2025 earnings per share estimates for shares of ResMed in a research ...
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?
Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.